Medical devices, healthcare technology and the business of care
PMA approval · P100010

ARCTIC FRONT CRYOCATHETER SYSTEM

Medtronic Cryocath, LP · Decision date Dec 17, 2010

MEDTECHLEDGER EXPLANATIONP100010

What did the FDA approve?

The FDA database entry for P100010 records an approval decision dated December 17, 2010, for the Arctic Front Cryocatheter System from Medtronic Cryocath, LP. The device is categorized as a percutaneous cardiac ablation catheter for treatment of atrial fibrillation under product code OAE.

The approval statement lists the indication as treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation. The entry does not include supplement type, supplement reason, or other fields describing a changed item or original scope, so no further detail about the approval's relationship to any prior PMA is available from these fields.

FDA approval order statement

APPROVAL OF THE ARCTIC FRONT CRYOCATHETER SYSTEM. THE DEVICE IS INDICATED FOR THE TREATMENT OF DRUG REFRACTORY RECURRENT SYMPTOMATIC PAROXYSMAL ATRIAL FIBRILLATION.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Dec 17, 2010

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P100010
Regulatory pathway
Premarket approval application
Product code
OAE
Decision code
APPR
Decision date
Dec 17, 2010
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation.

Product code
OAE
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P100010 received

    Application receipt date recorded by FDA.

  2. P100010 · FDA decision

    APPR

Timeline entries are records held by MedtechLedger for P100010. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P100010

Product / regulatory recordCompanyPathwayDecision dateSource
STOP Persistent AFP100010/S154
Medtronic Cryocath, LPPMA supplementSep 25, 2026FDA

Explore the linked device profile

Other records with product code OAE

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Cryocath, LP

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
8200 Coral Sea St., Ms Mv S46, Mounds View, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records